181 related articles for article (PubMed ID: 28094123)
1. Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling.
Sharma UC; Mosleh W; Chaudhari MR; Katkar R; Weil B; Evelo C; Cimato TR; Pokharel S; Blankesteijn WM; Suzuki G
Heart Lung Circ; 2017 Jul; 26(7):736-745. PubMed ID: 28094123
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades.
Wang X; Gaur M; Mounzih K; Rodriguez HJ; Qiu H; Chen M; Yan L; Cooper BA; Narayan S; Derakhshandeh R; Rao P; Han DD; Nabavizadeh P; Springer ML; John CM
Cardiovasc Res; 2023 Nov; 119(15):2536-2549. PubMed ID: 37602717
[TBL] [Abstract][Full Text] [Related]
3. Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping.
Perea RJ; Morales-Ruiz M; Ortiz-Perez JT; Bosch X; Andreu D; Borras R; Acosta J; Penela D; Prat-González S; de Caralt TM; Martínez M; Morales-Romero B; Lasalvia L; Donnelly J; Jiménez W; Mira A; Mont L; Berruezo A
Int J Cardiol; 2016 Nov; 223():458-464. PubMed ID: 27544605
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction.
van der Velde AR; Lexis CP; Meijers WC; van der Horst IC; Lipsic E; Dokter MM; van Veldhuisen DJ; van der Harst P; de Boer RA
Clin Chim Acta; 2016 Jan; 452():50-7. PubMed ID: 26528636
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 and post-myocardial infarction cardiac remodeling.
Meijers WC; van der Velde AR; Pascual-Figal DA; de Boer RA
Eur J Pharmacol; 2015 Sep; 763(Pt A):115-21. PubMed ID: 26101067
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 and cardiac function in survivors of acute myocardial infarction.
Weir RA; Petrie CJ; Murphy CA; Clements S; Steedman T; Miller AM; McInnes IB; Squire IB; Ng LL; Dargie HJ; McMurray JJ
Circ Heart Fail; 2013 May; 6(3):492-8. PubMed ID: 23505301
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic diastolic function evolution in patients with an anterior Q-wave myocardial infarction: insights from the REVE-2 study.
Ferreira JP; Bauters C; Eschalier R; Lamiral Z; Fay R; Huttin O; Girerd N; Zannad F; Pinet F; Rossignol P
ESC Heart Fail; 2019 Feb; 6(1):70-79. PubMed ID: 30460754
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 is expressed in the myocardium very early post-myocardial infarction.
Hashmi S; Al-Salam S
Cardiovasc Pathol; 2015; 24(4):213-23. PubMed ID: 25547609
[TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study.
Mosleh W; Chaudhari MR; Sonkawade S; Mahajan S; Khalil C; Frodey K; Shah T; Dahal S; Karki R; Katkar R; Blankesteijn WM; Page B; Pokharel S; Kim M; Sharma UC
Biomark Insights; 2018; 13():1177271918771969. PubMed ID: 29769800
[TBL] [Abstract][Full Text] [Related]
10. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
Shirakawa K; Endo J; Kataoka M; Katsumata Y; Yoshida N; Yamamoto T; Isobe S; Moriyama H; Goto S; Kitakata H; Hiraide T; Fukuda K; Sano M
Circulation; 2018 Oct; 138(18):2021-2035. PubMed ID: 29967195
[TBL] [Abstract][Full Text] [Related]
11. The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty.
Szadkowska I; Wlazeł RN; Migała M; Szadkowski K; Zielińska M; Paradowski M; Pawlicki L
Cardiol J; 2013; 20(6):577-82. PubMed ID: 24338533
[TBL] [Abstract][Full Text] [Related]
12. Temporal expression of galectin-3 following myocardial infarction.
Milner TD; Viner AC; MacKinnon AC; Sethi T; Flapan AD
Acta Cardiol; 2014 Dec; 69(6):595-602. PubMed ID: 25643429
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
[TBL] [Abstract][Full Text] [Related]
14. Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study.
Huttin O; Mandry D; Popovic B; Rossignol P; Odille F; Micard E; Lamiral Z; Zannad F; Girerd N; Marie PY
PLoS One; 2020; 15(5):e0232572. PubMed ID: 32392260
[TBL] [Abstract][Full Text] [Related]
15. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study.
George M; Shanmugam E; Srivatsan V; Vasanth K; Ramraj B; Rajaram M; Jena A; Sridhar A; Chaudhury M; Kaliappan I
Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):275-84. PubMed ID: 25814534
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
[TBL] [Abstract][Full Text] [Related]
17. Value and level of galectin-3 in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.
Tsai TH; Sung PH; Chang LT; Sun CK; Yeh KH; Chung SY; Chua S; Chen YL; Wu CJ; Chang HW; Ko SF; Yip HK
J Atheroscler Thromb; 2012; 19(12):1073-82. PubMed ID: 23037954
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.
Bao MW; Zhang XJ; Li L; Cai Z; Liu X; Wan N; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
J Pathol; 2015 Jul; 236(3):360-72. PubMed ID: 25726944
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
Asleh R; Enriquez-Sarano M; Jaffe AS; Manemann SM; Weston SA; Jiang R; Roger VL
J Am Coll Cardiol; 2019 May; 73(18):2286-2295. PubMed ID: 31072572
[TBL] [Abstract][Full Text] [Related]
20. HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism.
Li J; Zhang Y; Li C; Xie J; Liu Y; Zhu W; Zhang X; Jiang S; Liu L; Ding Z
Cardiovasc Res; 2013 Sep; 99(4):674-84. PubMed ID: 23729663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
